Value through Innovation27 July 2016

Clinical Study Results

  • BI 409306 - Schizophrenia
    Clinical Study Number 1289.6
    Study Indication Schizophrenia
    Product BI 409306
    Generic Name BI 409306
    Lab Code BI 409306
    Clinical Phase II
    Study Title

    A phase II randomised, double-blinded, placebo-controlled study to evaluate the efficacy, safety, and tolerability of four orally administrated doses of BI 409306 during a 12-week treatment period in patients with schizophrenia on stable antipsychotic treatment

    Study Document Lay summary 1289.6 english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.